TrialHepatology communications2026

Safety and efficacy of libevitug in patients with chronic hepatitis B and D virus coinfection: A single-center, open-label, phase IIa trial in China.

Xinrui Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.